search
Back to results

Impact of Balanced Slat Colloid HES 130/0.42 on Coagulation Profiles in Patients Undergoing Spinal Cord Tumor Surgery

Primary Purpose

Coagulation

Status
Terminated
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Valanced salt colloid
Valanced salt crystalloid group
Sponsored by
Yonsei University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Coagulation focused on measuring balanced salt colloid, coagulation profiles, spinal cord tumor

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • adult patients over the age of 20 scheduled for spinal tumor removal and fixation

Exclusion Criteria:

  • 1. Renal failure 2. Preexisting congestive heart failure(NYHA III ~ IV) 3. Anemia 4. Coagulopathy 5. Abnormal liver function 6. Anti coagulation/Anti platelet ,edication 7. Foreigner, illiterate 8. Disabled person,

Sites / Locations

  • Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Valanced salt colloid group

Valanced salt crystalloid group

Arm Description

Outcomes

Primary Outcome Measures

Compare the effect of coagulation profile in patients receiving intraoperative balanced salt colloid undergoing spinal cord tumor surgery.
ROTEM, CBC, PT/aPTT,ABGA, Lactic acid, electrolyte

Secondary Outcome Measures

Full Information

First Posted
August 8, 2013
Last Updated
March 27, 2019
Sponsor
Yonsei University
search

1. Study Identification

Unique Protocol Identification Number
NCT01921595
Brief Title
Impact of Balanced Slat Colloid HES 130/0.42 on Coagulation Profiles in Patients Undergoing Spinal Cord Tumor Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
December 2015
Overall Recruitment Status
Terminated
Why Stopped
It ended early because it would not be possible to meet the target number.
Study Start Date
August 2013 (undefined)
Primary Completion Date
January 31, 2015 (Actual)
Study Completion Date
January 31, 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yonsei University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of study is to compare the effect of coagulation profile in patients receiving intraoperative balanced salt colloid undergoing spinal cord tumor surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coagulation
Keywords
balanced salt colloid, coagulation profiles, spinal cord tumor

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
6 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Valanced salt colloid group
Arm Type
Experimental
Arm Title
Valanced salt crystalloid group
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Valanced salt colloid
Intervention Description
Maximum dose : 30ml/kg, IV, The infusion of valanced salt colloid is started at bleeding and continued until reach at maximum dose
Intervention Type
Other
Intervention Name(s)
Valanced salt crystalloid group
Intervention Description
Maximum dose : 30ml/kg, IV, The infusion of valanced salt crystalloid is started at bleeding and continued until reach at maximum dose
Primary Outcome Measure Information:
Title
Compare the effect of coagulation profile in patients receiving intraoperative balanced salt colloid undergoing spinal cord tumor surgery.
Description
ROTEM, CBC, PT/aPTT,ABGA, Lactic acid, electrolyte
Time Frame
up to 24hrs after anesthesia induction

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: adult patients over the age of 20 scheduled for spinal tumor removal and fixation Exclusion Criteria: 1. Renal failure 2. Preexisting congestive heart failure(NYHA III ~ IV) 3. Anemia 4. Coagulopathy 5. Abnormal liver function 6. Anti coagulation/Anti platelet ,edication 7. Foreigner, illiterate 8. Disabled person,
Facility Information:
Facility Name
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine
City
Seoul
ZIP/Postal Code
120-752
Country
Korea, Republic of

12. IPD Sharing Statement

Learn more about this trial

Impact of Balanced Slat Colloid HES 130/0.42 on Coagulation Profiles in Patients Undergoing Spinal Cord Tumor Surgery

We'll reach out to this number within 24 hrs